Suppr超能文献

从基础向系统药效动力学模型转变。

Moving from basic toward systems pharmacodynamic models.

机构信息

Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York 14214, USA.

出版信息

J Pharm Sci. 2013 Sep;102(9):2930-40. doi: 10.1002/jps.23590. Epub 2013 May 16.

Abstract

Building upon many classical foundations of pharmacology, a diverse array of mechanistic pharmacokinetic-pharmacodynamic (PK/PD) models have emerged based on mechanisms of drug action and primary rate-limiting or turnover processes in physiology. An array of basic models can be extended to handle various complexities including tolerance and can readily be employed as building blocks in assembling enhanced PK/PD or small systems models. Our corticosteroid models demonstrate these concepts as well as elements of horizontal and vertical integration of molecular to whole-body processes. The potential advantages and challenges in moving PK/PD toward systems models are described.

摘要

在药理学的许多经典基础上,已经出现了基于药物作用机制和生理学中主要限速或周转过程的多样化的机制药代动力学-药效动力学(PK/PD)模型。一系列基本模型可以扩展以处理各种复杂性,包括耐受性,并且可以很容易地用作组装增强的 PK/PD 或小系统模型的构建块。我们的皮质类固醇模型展示了这些概念,以及分子到全身过程的水平和垂直整合的要素。还描述了将 PK/PD 推向系统模型的潜在优势和挑战。

相似文献

1
Moving from basic toward systems pharmacodynamic models.
J Pharm Sci. 2013 Sep;102(9):2930-40. doi: 10.1002/jps.23590. Epub 2013 May 16.
2
Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.
Pharmacol Rev. 2020 Apr;72(2):414-438. doi: 10.1124/pr.119.018101.
3
Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.
Int J Clin Pharmacol Ther. 1997 Oct;35(10):401-13.
4
Application of pharmacometrics and quantitative systems pharmacology to cancer therapy: The example of luminal a breast cancer.
Pharmacol Res. 2017 Oct;124:20-33. doi: 10.1016/j.phrs.2017.07.015. Epub 2017 Jul 19.
5
Systems pharmacology and enhanced pharmacodynamic models for understanding antibody-based drug action and toxicity.
MAbs. 2017 Jan;9(1):15-28. doi: 10.1080/19420862.2016.1238995. Epub 2016 Sep 23.
6
Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives.
Pharm Res. 1999 Feb;16(2):176-85. doi: 10.1023/a:1011907920641.
8
Incorporating receptor theory in mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling.
Drug Metab Pharmacokinet. 2009;24(1):3-15. doi: 10.2133/dmpk.24.3.
9
Automated analysis of routinely generated preclinical pharmacokinetic and pharmacodynamic data.
J Bioinform Comput Biol. 2014 Jun;12(3):1450010. doi: 10.1142/S0219720014500103. Epub 2014 Mar 6.
10
Sobol Sensitivity Analysis: A Tool to Guide the Development and Evaluation of Systems Pharmacology Models.
CPT Pharmacometrics Syst Pharmacol. 2015 Feb;4(2):69-79. doi: 10.1002/psp4.6.

引用本文的文献

1
Application of machine learning in combination with mechanistic modeling to predict plasma exposure of small molecules.
Front Syst Biol. 2023 Jun 20;3:1180948. doi: 10.3389/fsysb.2023.1180948. eCollection 2023.
2
Application of Physiologically-Based Pharmacokinetic (PBPK) Model in Drug Development and in Dietary Phytochemicals.
Curr Pharmacol Rep. 2025;11(1):45. doi: 10.1007/s40495-025-00427-w. Epub 2025 Aug 8.
3
Digital twin-enhanced three-organ microphysiological system for studying drug pharmacokinetics in pregnant women.
Front Pharmacol. 2025 Feb 12;16:1528748. doi: 10.3389/fphar.2025.1528748. eCollection 2025.
5
Formulation and Validation of an Extended Sigmoid Emax Model in Pharmacodynamics.
Pharm Res. 2024 Sep;41(9):1787-1795. doi: 10.1007/s11095-024-03752-9. Epub 2024 Aug 14.
7
Computational analysis of 5-fluorouracil anti-tumor activity in colon cancer using a mechanistic pharmacokinetic/pharmacodynamic model.
PLoS Comput Biol. 2022 Nov 17;18(11):e1010685. doi: 10.1371/journal.pcbi.1010685. eCollection 2022 Nov.
9
10
Towards a comprehensive assessment of QSP models: what would it take?
J Pharmacokinet Pharmacodyn. 2024 Oct;51(5):521-531. doi: 10.1007/s10928-022-09820-0. Epub 2022 Aug 13.

本文引用的文献

1
NIH Support for the Emergence of Quantitative and Systems Pharmacology.
CPT Pharmacometrics Syst Pharmacol. 2013 Apr 10;2(4):e37. doi: 10.1038/psp.2013.13.
2
Physiologically based pharmacokinetic models for everolimus and sorafenib in mice.
Cancer Chemother Pharmacol. 2013 May;71(5):1219-29. doi: 10.1007/s00280-013-2116-y. Epub 2013 Mar 3.
3
Applications of minimal physiologically-based pharmacokinetic models.
J Pharmacokinet Pharmacodyn. 2012 Dec;39(6):711-23. doi: 10.1007/s10928-012-9280-2. Epub 2012 Nov 23.
4
Pharmacokinetic/pharmacodynamic modeling in inflammation.
Crit Rev Biomed Eng. 2012;40(4):295-312. doi: 10.1615/critrevbiomedeng.v40.i4.50.
5
Merging systems biology with pharmacodynamics.
Sci Transl Med. 2012 Mar 21;4(126):126ps7. doi: 10.1126/scitranslmed.3003563.
6
Physiologically-based pharmacokinetics in drug development and regulatory science.
Annu Rev Pharmacol Toxicol. 2011;51:45-73. doi: 10.1146/annurev-pharmtox-010510-100540.
8
A physiologically based mathematical model of integrated calcium homeostasis and bone remodeling.
Bone. 2010 Jan;46(1):49-63. doi: 10.1016/j.bone.2009.08.053. Epub 2009 Sep 2.
9
Feedback loops shape cellular signals in space and time.
Science. 2008 Oct 17;322(5900):390-5. doi: 10.1126/science.1160617.
10
Quantitative disease, drug, and trial models.
Annu Rev Pharmacol Toxicol. 2009;49:291-301. doi: 10.1146/annurev.pharmtox.011008.145613.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验